Journal for ImmunoTherapy of Cancer
Journal Title
- Journal for ImmunoTherapy of Cancer
ISSN
- P 2051-1426
Publisher
- BioMed Central
Listed on(Coverage)
| JCR | 2017-2019 |
|---|---|
| SJR | 2014-2019 |
| CiteScore | 2016-2019 |
| SCIE | 2017-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| DOAJ | 2017-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | tumour immunology, cancer immunotherapy, immunotherapy biomarkers |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY-NC, CC BY, CC BY-NC-ND |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity. JITC publishes high quality original research articles, literature reviews, position papers and practice guidelines, and case reports; invited commentaries may also be commissioned by the journal. Together, these articles make JITC the leading forum for research in tumor immunology and cancer immunotherapy.
Homepage
Article List
1 - 0 out of 0 results.
1